Your browser doesn't support javascript.
loading
A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
Toso, Anna; Leoncini, Mario; Maioli, Mauro; Tropeano, Francesco; Villani, Simona; Bellandi, Francesco.
Affiliation
  • Toso A; Division of Cardiology, Santo Stefano Hospital, Prato, Italy, anna.toso@libero.it.
  • Leoncini M; Division of Cardiology, Santo Stefano Hospital, Prato, Italy.
  • Maioli M; Division of Cardiology, Santo Stefano Hospital, Prato, Italy.
  • Tropeano F; Division of Cardiology, Santo Stefano Hospital, Prato, Italy.
  • Villani S; Section of Biostatistics and Clinical Epidemiology, Department of Public Health, Neurosciences, Experimental and Forensic Medicine, Pavia University, Pavia, Italy.
  • Bellandi F; Division of Cardiology, Santo Stefano Hospital, Prato, Italy.
Cardiorenal Med ; 10(5): 288-301, 2020.
Article in En | MEDLINE | ID: mdl-32434204
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Angiography / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Contrast Media / Acute Kidney Injury / Atorvastatin Limits: Humans Language: En Journal: Cardiorenal Med Year: 2020 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Angiography / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Contrast Media / Acute Kidney Injury / Atorvastatin Limits: Humans Language: En Journal: Cardiorenal Med Year: 2020 Document type: Article Country of publication: Switzerland